Generic placeholder image

Clinical Immunology, Endocrine & Metabolic Drugs (Discontinued)

Editor-in-Chief

ISSN (Print): 2212-7070
ISSN (Online): 2212-7089

Recent Advances in Clinical Immunology, Endocrine & Metabolic Drugs: An Editorial Overview

Author(s): Thea Magrone and Emilio Jirillo

Volume 1, Issue 2, 2014

Page: [61 - 62] Pages: 2

DOI: 10.2174/221270700102150604120418

Abstract

An analytical review of the articles published in the two issues of Clinical Immunology Endocrine Metabolic Drugs (volume 1, 2014) is reported. Various topics are covered in volume 1 of the journal. Clinical Immunology is represented in six articles related to nickel hypersensitivity (2 articles), therapeutic approaches in human tuberculosis, immune biomarkers in trauma patients, salivary cytokines in normal weight children and oral sensitization in rats. Endocrinology is the main topic of the two articles dealing with polycystic ovary syndrome and androgen receptor antagonists in prostate cancer. The vascular pathophysiology is the major theme of two papers dealing with the role of angiotensin II and post-prandial oxidative burst. Finally, a paper is devoted to antibiotics resistance of four probiotics.

Keywords: Clinical immunology, endocrinology, metabolism, drug targets.


© 2024 Bentham Science Publishers | Privacy Policy